Clinical trial

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer

NCT00003860

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1998-09-01

PhasePHASE2

Study timeline

Study start (actual)1998-09-01Date precision: month

Registry last updated2021-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

filgrastimBIOLOGICAL

carboplatinDRUG · verified · RxNorm: carboplatin

etoposideDRUG · verified · RxNorm: etoposide

ifosfamideDRUG · verified · RxNorm: ifosfamide

in vitro-treated peripheral blood stem cell transplantationPROCEDURE

Sponsors & collaborators

UNICANCERlead sponsor

Mapped research locations

ParisFrance3 MontpellierFrance2 LyonFrance2 ToulouseFrance1 MarseilleFrance1 StrasbourgFrance1 BordeauxFrance1 NiceFrance1 DijonFrance1 VillejuifFrance1 GrenobleFrance1 BesançonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003860 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.